161 related articles for article (PubMed ID: 36742181)
1. PRPS2 mutations drive acute lymphoblastic leukemia relapse through influencing PRPS1/2 hexamer stability.
Song L; Li P; Sun H; Ding L; Wang J; Li B; Zhou BS; Feng H; Li Y
Blood Sci; 2023 Jan; 5(1):39-50. PubMed ID: 36742181
[TBL] [Abstract][Full Text] [Related]
2. Negative feedback-defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL.
Li B; Li H; Bai Y; Kirschner-Schwabe R; Yang JJ; Chen Y; Lu G; Tzoneva G; Ma X; Wu T; Li W; Lu H; Ding L; Liang H; Huang X; Yang M; Jin L; Kang H; Chen S; Du A; Shen S; Ding J; Chen H; Chen J; von Stackelberg A; Gu L; Zhang J; Ferrando A; Tang J; Wang S; Zhou BB
Nat Med; 2015 Jun; 21(6):563-71. PubMed ID: 25962120
[TBL] [Abstract][Full Text] [Related]
3. Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia.
Li B; Brady SW; Ma X; Shen S; Zhang Y; Li Y; Szlachta K; Dong L; Liu Y; Yang F; Wang N; Flasch DA; Myers MA; Mulder HL; Ding L; Liu Y; Tian L; Hagiwara K; Xu K; Zhou X; Sioson E; Wang T; Yang L; Zhao J; Zhang H; Shao Y; Sun H; Sun L; Cai J; Sun HY; Lin TN; Du L; Li H; Rusch M; Edmonson MN; Easton J; Zhu X; Zhang J; Cheng C; Raphael BJ; Tang J; Downing JR; Alexandrov LB; Zhou BS; Pui CH; Yang JJ; Zhang J
Blood; 2020 Jan; 135(1):41-55. PubMed ID: 31697823
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9-Mediated Induction of Relapse-Specific
Nguyen TTT; Tanaka Y; Sanada M; Hosaka M; Tamai M; Kagami K; Komatsu C; Somazu S; Harama D; Kasai S; Watanabe A; Akahane K; Goi K; Inukai T
Mol Pharmacol; 2023 Apr; 103(4):199-210. PubMed ID: 36669880
[TBL] [Abstract][Full Text] [Related]
5. FPGS relapse-specific mutations in relapsed childhood acute lymphoblastic leukemia.
Yu SL; Zhang H; Ho BC; Yu CH; Chang CC; Hsu YC; Ni YL; Lin KH; Jou ST; Lu MY; Chen SH; Wu KH; Wang SC; Chang HH; Pui CH; Yang JJ; Zhang J; Lin DT; Lin SW; Ma X; Yang YL
Sci Rep; 2020 Jul; 10(1):12074. PubMed ID: 32694622
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism of c-Myc and PRPS1/2 against thiopurine resistance in Burkitt's lymphoma.
Li T; Song L; Zhang Y; Han Y; Zhan Z; Xv Z; Li Y; Tang Y; Yang Y; Wang S; Li S; Zheng L; Li Y; Gao Y
J Cell Mol Med; 2020 Jun; 24(12):6704-6715. PubMed ID: 32391636
[TBL] [Abstract][Full Text] [Related]
7. PRPS1-mediated purine biosynthesis is critical for pluripotent stem cell survival and stemness.
Yang Y; Song L; Huang X; Feng Y; Zhang Y; Liu Y; Li S; Zhan Z; Zheng L; Feng H; Li Y
Aging (Albany NY); 2021 Jan; 13(3):4063-4078. PubMed ID: 33493137
[TBL] [Abstract][Full Text] [Related]
8. Mechanosensitive turnover of phosphoribosyl pyrophosphate synthetases regulates nucleotide metabolism.
Li J; Shao J; Zeng Z; He Y; Tang C; Park SH; Lee JH; Liu R
Cell Death Differ; 2022 Jan; 29(1):206-217. PubMed ID: 34465890
[TBL] [Abstract][Full Text] [Related]
9. Conversion of PRPS Hexamer to Monomer by AMPK-Mediated Phosphorylation Inhibits Nucleotide Synthesis in Response to Energy Stress.
Qian X; Li X; Tan L; Lee JH; Xia Y; Cai Q; Zheng Y; Wang H; Lorenzi PL; Lu Z
Cancer Discov; 2018 Jan; 8(1):94-107. PubMed ID: 29074724
[TBL] [Abstract][Full Text] [Related]
10. Increase of PRPP enhances chemosensitivity of PRPS1 mutant acute lymphoblastic leukemia cells to 5-Fluorouracil.
Wang D; Chen Y; Fang H; Zheng L; Li Y; Yang F; Xu Y; Du L; Zhou BS; Li H
J Cell Mol Med; 2018 Dec; 22(12):6202-6212. PubMed ID: 30255549
[TBL] [Abstract][Full Text] [Related]
11. NUDT15 polymorphism and NT5C2 and PRPS1 mutations influence thiopurine sensitivity in acute lymphoblastic leukaemia cells.
Somazu S; Tanaka Y; Tamai M; Watanabe A; Kagami K; Abe M; Harama D; Shinohara T; Akahane K; Goi K; Sugita K; Moriyama T; Yang J; Goto H; Minegishi M; Iwamoto S; Takita J; Inukai T
J Cell Mol Med; 2021 Nov; 25(22):10521-10533. PubMed ID: 34636169
[TBL] [Abstract][Full Text] [Related]
12. Thiopurine Resistance in Childhood ALL Is Mediated by PRPS1 Mutations.
Cancer Discov; 2015 Jul; 5(7):693. PubMed ID: 25998402
[TBL] [Abstract][Full Text] [Related]
13. Phosphoribosyl-pyrophosphate synthetase 2 (PRPS2) depletion regulates spermatogenic cell apoptosis and is correlated with hypospermatogenesis.
Lei B; Xie LX; Zhang SB; Wan B; Zhong LR; Zhou XM; Mao XM; Shu FP
Asian J Androl; 2020; 22(5):493-499. PubMed ID: 31736475
[TBL] [Abstract][Full Text] [Related]
14. Phosphoribosyl pyrophosphate synthetases 2 knockdown inhibits prostate cancer progression by suppressing cell cycle and inducing cell apoptosis.
Qiao H; Tan X; Lv DJ; Xing RW; Shu FP; Zhong CF; Li C; Zou YG; Mao XM
J Cancer; 2020; 11(5):1027-1037. PubMed ID: 31956349
[TBL] [Abstract][Full Text] [Related]
15. Arginylation regulates purine nucleotide biosynthesis by enhancing the activity of phosphoribosyl pyrophosphate synthase.
Zhang F; Patel DM; Colavita K; Rodionova I; Buckley B; Scott DA; Kumar A; Shabalina SA; Saha S; Chernov M; Osterman AL; Kashina A
Nat Commun; 2015 Jul; 6():7517. PubMed ID: 26175007
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of human PRPS2 filaments.
Lu GM; Hu HH; Chang CC; Zhong J; Zhou X; Guo CJ; Zhang T; Li YL; Yin B; Liu JL
Cell Biosci; 2023 May; 13(1):100. PubMed ID: 37248548
[TBL] [Abstract][Full Text] [Related]
17. Expression of phosphoribosyl pyrophosphate synthetase genes in U87 glioma cells with ERN1 knockdown: effect of hypoxia and endoplasmic reticulum stress.
Minchenko OH; Garmash IA; Kovalevska OV; Tsymbal DO; Minchenko DO
Ukr Biochem J; 2014; 86(6):74-83. PubMed ID: 25816608
[TBL] [Abstract][Full Text] [Related]
18. Promoter regions of the human X-linked housekeeping genes PRPS1 and PRPS2 encoding phosphoribosylpyrophosphate synthetase subunit I and II isoforms.
Ishizuka T; Iizasa T; Taira M; Ishijima S; Sonoda T; Shimada H; Nagatake N; Tatibana M
Biochim Biophys Acta; 1992 Mar; 1130(2):139-48. PubMed ID: 1314091
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of
Moriyama T; Liu S; Li J; Meyer J; Zhao X; Yang W; Shao Y; Heath R; Hnízda A; Carroll WL; Yang JJ
Mol Cancer Ther; 2019 Oct; 18(10):1887-1895. PubMed ID: 31358663
[TBL] [Abstract][Full Text] [Related]
20. Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer.
Cunningham JT; Moreno MV; Lodi A; Ronen SM; Ruggero D
Cell; 2014 May; 157(5):1088-103. PubMed ID: 24855946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
